BioNTech SE Cash Flow Statement

Cash Flow Statement Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -0.10B-0.06B-0.20B0.02B11.77B9.63B1.00B-0.71B
Share-based Compensation 0.01B0.01B0.03B0.04B0.11B0.11B0.06B0.11B
Gains from Investment Securities -0.00B0.00B-0.00B-0.00B-0.01B-0.00B-0.00B0.00B
Cash from Operations -0.06B-0.07B-0.22B-0.02B1.02B13.85B5.78B0.22B
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) 0.01B0.03B0.04B0.05B0.09B0.13B0.20B0.32B
Change in Working Capital
Change in Receivables -0.00B-0.00B0.00B-0.00B
Change in Inventory -0.00B-0.00B-0.01B-0.06B-0.50B0.06B0.09B0.08B
Investing Activities
Capital Expenditures 0.03B0.04B0.04B0.08B0.15B0.34B0.27B0.31B
Sales of Property, Plant and Equipment 0.01B0.00B0.00B0.00B0.00B-0.00B0.00B
Change in Intangibles -0.00B-0.00B-0.00B-0.02B-0.03B-0.03B-0.49B-0.18B
Acquisitions -0.00B-0.07B-0.02B-0.36B
Cash from Investing Activities -0.06B-0.08B-0.09B-0.17B-0.65B-0.04B-7.48B-2.22B
Financing Activities
Cash from Financing Activities -0.00B0.43B0.42B1.07B0.11B-1.45B-0.84B-0.05B
Dividend Payments
Dividends Paid - Common 0.49B
Additional items
Exchange Rate Effect -0.03B-0.00B-0.05B0.07B0.06B-0.02B0.02B
Change in Cash -0.12B0.28B0.12B0.88B0.48B12.37B-2.54B-2.05B
Free Cash Flow -0.09B-0.10B-0.26B-0.09B0.87B13.52B5.51B-0.08B
Net Cash Flow -0.12B0.28B0.12B0.88B0.48B12.37B-2.54B-2.05B